• News and Events

    • Reuters: U.S. prescription drug spending to hit $400 billion a year by 2020: IMS

      14-04-2016

      U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc on Thursday.

    • Bloomberg: Prescription Drug Spending Hits Record $425 Billion in U.S.

      14-04-2016

      Spending on prescription drugs in the U.S. rose 12 percent to a record $425 billion before discounts last year, boosted in part by the introduction of breakthrough medicines for cancer and the growing number of patients seeking treatment for hepatitis C.

    • Wall Street Journal: U.S. Drug Spending Climbs

      14-04-2016

      Total spending on prescription drugs in the U.S. rose 12.2% to nearly $425 billion in 2015, continuing a steep climb fueled by the introduction in recent years of expensive new drugs for cancer and infections, as well as price hikes for older drugs, according to a new report.

    • Associated Press: Report: US medicine spending up 8.5 percent 2015

      14-04-2016

      A report from data firm IMS Health estimates patients, insurers, government programs and other payers spent a combined $309.5 billion last year on prescription medicines.

    • Forbes: Double-Digit Growth In Drug Spending Slows As Insurers Fight Back

      14-04-2016

      Thanks to rebates and other concessions awarded by pharma companies angling to get their new products onto insurance formularies, the net spending on drugs was $310 billion in 2015, growing only 8.5% from the previous year. And the average net price for existing brands rose just 2.8%—a significantly lower rate of growth than what was seen in previous years.

    • Healthcare BPO: IMS Health Shares Benefits and Trends of Outsourcing within the Healthcare Industry

      30-11-2015

      Software Magazine

      A recent study of the Global Healthcare Business Process Outsourcing (BPO) by Research and Markets, Global Healthcare BPO Market 2015 – 2019, indicates growth at a compound annual growth rate of 5.32 percent over the period of 2014 to 2019.

    • Which Way Now For Mid-Sized European Pharmas?

      25-11-2015

      Executive Summary

      Compared with their top 20 European peers and with similarly sized companies in the US, many mid-sized European pharmas are struggling. IMS Health analyzes the predicament these companies find themselves in and outlines what they need to do to avoid being caught in an evolutionary backwater.

    • 7 Stunning Findings Regarding Global Medicine Use by 2020

      21-11-2015

      The Motley Fool

      What does the future hold for global drug spending? According to the latest report from the IMS Institute for Healthcare Informatics, there are a number of surprising findings.

    • Identifying Switch Opportunities Worldwide

      16-09-2015

      OTCToolBox Innovations

      IMS Health's Andy Tisman is featured in this OTCToolBox Innovations article sharing key consumer health insights regarding the global trend of switching medicines from prescription to non-prescription status.

    • Cloud Marketing: Cloud Control

      15-07-2015

      MM&M

      To unlock the vast business potential of the cloud, pharma must first overcome its inherent resistance to change and then commit to tearing down those silo walls.

    • An Inside Look Into Developing an Apple Watch Platform

      24-06-2015

      PM360

      IMS Health announced a new wearable app platform that is entirely dedicated to the life science industry. The platform, called IMSHealthWear 1.00, will also serve as the basis for two new apps: MGRWear and REPWear.

See More